Inactive Instrument

All News ProNAi Therapeutics Inc Nasdaq

Equities

US74346L1017

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sierra Oncology, Inc. Announces Update on Sra737	23-03-06	CI
Sareum Holdings Says GSK Completes Acquisition of Sierra Oncology	22-07-04	DJ
Sierra Oncology, Inc.(NasdaqGM:SRRA) dropped from NASDAQ Composite Index	22-07-04	CI
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
Sierra Oncology : Statement of Changes in Beneficial Ownership (Form 4)	22-07-01	PU
SIERRA ONCOLOGY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-07-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ProNAi Therapeutics Inc Nasdaq

Equities

US74346L1017

All News

Filters